Literature DB >> 30733340

Protein kinase Cα-mediated phosphorylation of Twist1 at Ser-144 prevents Twist1 ubiquitination and stabilizes it.

Roslyn Tedja1, Cai M Roberts1, Ayesha B Alvero1, Carlos Cardenas1, Yang Yang-Hartwich1, Sydney Spadinger1, Mary Pitruzzello1, Gang Yin2, Carlotta A Glackin3, Gil Mor4.   

Abstract

Twist1 is a basic helix-loop-helix transcription factor that plays a key role in embryonic development, and its expression is down-regulated in adult cells. However, Twist1 is highly expressed during cancer development, conferring a proliferative, migratory, and invasive phenotype to malignant cells. Twist1 expression can be regulated post-translationally by phosphorylation or ubiquitination events. We report in this study a previously unknown and relevant Twist1 phosphorylation site that controls its stability. To identify candidate phosphorylation sites in Twist1, we first conducted an in silico analysis of the Twist1 protein, which yielded several potential sites. Because most of these sites were predicted to be phosphorylated by protein kinase C (PKC), we overexpressed PKCα in several cell lines and found that it phosphorylates Twist1 on Ser-144. Using a combination of immunoblotting, immunoprecipitation, protein overexpression, and CRISPR/Cas9-mediated PKCα knockout experiments, we observed that PKCα-mediated Twist1 phosphorylation at Ser-144 inhibits Twist1 ubiquitination and consequently stabilizes it. These results provide evidence for a direct association between PKCα and Twist1 and yield critical insights into the PKCα/Twist1 signaling axis that governs cancer aggressiveness.
© 2019 Tedja et al.

Entities:  

Keywords:  NetphosK3.1; PKCalpha; Twist1; embryonic development; epithelial-mesenchymal transition (EMT); ovarian cancer; phosphorylation; post-transcriptional regulation; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2019        PMID: 30733340      PMCID: PMC6442047          DOI: 10.1074/jbc.RA118.005921

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells.

Authors:  Kazuo Asanoma; Ge Liu; Takako Yamane; Yoko Miyanari; Tomoka Takao; Hiroshi Yagi; Tatsuhiro Ohgami; Akimasa Ichinoe; Kenzo Sonoda; Norio Wake; Kiyoko Kato
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

2.  Protein kinase Cα mediates erlotinib resistance in lung cancer cells.

Authors:  Mahlet B Abera; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2015-02-27       Impact factor: 4.436

Review 3.  A TWIST in development.

Authors:  C S Rose; S Malcolm
Journal:  Trends Genet       Date:  1997-10       Impact factor: 11.639

4.  Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location.

Authors:  V El Ghouzzi; L Legeai-Mallet; S Aresta; C Benoist; A Munnich; J de Gunzburg; J Bonaventure
Journal:  Hum Mol Genet       Date:  2000-03-22       Impact factor: 6.150

5.  Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation.

Authors:  Louise R Howe; Osamu Watanabe; James Leonard; Anthony M C Brown
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

6.  Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.

Authors:  M Tan; P Li; M Sun; G Yin; D Yu
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

7.  PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.

Authors:  Ying Chen; Guanzhen Yu; Danghui Yu; Minghua Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-08-05

8.  Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.

Authors:  Jiateng Zhong; Kohei Ogura; Zhiwei Wang; Hiroyuki Inuzuka
Journal:  Discov Med       Date:  2013-01       Impact factor: 2.970

9.  Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity.

Authors:  Drazen Šošić; James A Richardson; Kai Yu; David M Ornitz; Eric N Olson
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

10.  Twist expression promotes migration and invasion in hepatocellular carcinoma.

Authors:  Noriyuki Matsuo; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Naoki Ueda; Shigetomi Tanaka; Shinichi Nishina; Yutaka Nakanishi; Masayuki Uemura; Akinobu Takaki; Shinichiro Nakamura; Yoshiyuki Kobayashi; Kazuhiro Nouso; Takahito Yagi; Kazuhide Yamamoto
Journal:  BMC Cancer       Date:  2009-07-18       Impact factor: 4.430

View more
  6 in total

Review 1.  Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.

Authors:  Zhao Huang; Zhe Zhang; Chengwei Zhou; Lin Liu; Canhua Huang
Journal:  MedComm (2020)       Date:  2022-05-18

Review 2.  Twist1: A Double-Edged Sword in Kidney Diseases.

Authors:  Jiafa Ren; Steven D Crowley
Journal:  Kidney Dis (Basel)       Date:  2020-01-17

Review 3.  The complexities of PKCα signaling in cancer.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Adv Biol Regul       Date:  2020-11-23

4.  MicroRNA-149 suppresses osteogenic differentiation of mesenchymal stem cells via inhibition of AKT1-dependent Twist1 phosphorylation.

Authors:  Jingzhang Fan; Shiming Li; Dawei Wang
Journal:  Cell Death Discov       Date:  2022-01-10

Review 5.  The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis.

Authors:  Eunjeong Kang; Jihye Seo; Haelim Yoon; Sayeon Cho
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

6.  CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential.

Authors:  Juanni Li; Ayesha B Alvero; Sudhakar Nuti; Roslyn Tedja; Cai M Roberts; Mary Pitruzzello; Yimin Li; Qing Xiao; Sai Zhang; Yaqi Gan; Xiaoying Wu; Gil Mor; Gang Yin
Journal:  Oncogene       Date:  2020-03-23       Impact factor: 8.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.